Austin, TX, United States of America

Daniel David Bensimon

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel David Bensimon

Introduction

Daniel David Bensimon is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of therapeutic agents, holding a total of 3 patents. His work focuses on improving the solubility of therapeutic agents and developing innovative compounds for cancer treatment.

Latest Patents

Bensimon's latest patents include methods and compositions aimed at enhancing the solubility of therapeutic agents. One of his notable inventions involves mixing fullerene in a lipid solution to create a lipofullerene mixture, which can improve the solubility of therapeutic agents. Another significant patent details the use of lipofullerene-saccharide conjugates as antimetastatic agents. This invention outlines a method for inhibiting the metastasis of neoplastic cells, including various types of cancer cells such as pancreatic, prostate, lung, breast, colon, and brain cancer cells. The effectiveness of these compounds has been demonstrated in a metastatic nude-mouse model of human pancreatic cancer.

Career Highlights

Bensimon is currently associated with Livepet, LLC, where he continues to innovate in the field of therapeutic solutions. His work has garnered attention for its potential impact on cancer treatment and the improvement of drug solubility.

Collaborations

Bensimon has collaborated with notable colleagues, including Ian Mitchell and Ayyappan Subbiah, to further advance his research and inventions.

Conclusion

Daniel David Bensimon's contributions to the field of therapeutic agents and cancer treatment exemplify the spirit of innovation. His patents reflect a commitment to improving medical solutions and enhancing the efficacy of treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…